Data dictionary : Conticabase

Patient (15 items)

Centre (ConticaBase)
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Centre ConticaBase
Possible values : MEDIPATH Toulouse, Cabinet de Reims, Centre Patho de Metz, Cabinet de Douai, Cabinet d’Amiens, IHP Nantes, Centre Patho Dijon, Cabinet de la Roquette, Cabinet Mathurin, Lyon CLB, Hôp. Gabriel Montpied, CHRU De Dijon, Hôp. Pontchaillou, Hôp. Charles Nicolle, Hôp Pasteur, CHU Amiens, Labo. de Limoges, Service d'anapath de Brest, Cy-Path, Cabinet de Rennes, Villejuif IGR, Milan INT, Padova UNIPD, KLEUVEN, CHRU Lille, Saint-Louis, Bergonié, Curie, Mannheim, Nice CAL, Dijon CGFL, Caen CFB, Marseille IPC, Nancy ICL, Lille COL, Lausanne, Montpellier ICM, Angers ICO, Nantes ICO , IUCT Toulouse, Strasbourg CHU, Bruxelles, CJP, Paris Henri Mondor, Warsaw Cancer Center, Timone, Cochin, Rennes CEM, Heidelberg, Bonn, Tübingen, Haut-Lévèque Bordeaux, LUMC, Ambroise Paré APHP, Nantes CHU, Tours Trousseau, CPS Strasbourg, CHRU Montpellier, Limoges Dupuytren, Rouen CHB, Lyon IHOP, St Etienne ICLN-CHU, Reims IJG, Reims CHU, Besançon CHU, La Réunion CHU, Tenon, Bicêtre, Pitié Salpétrière, GHSN - LYON, Hôp. Civil Strasbourg, CHRU Caen, CHRU Brest, CHU Nancy, Rangueil Toulouse, Purpan Toulouse, Centre Hospitalier - Lille, CHRU Angers, Hôp. Nord Marseille, MEDIPATH (Frejus), APHP Bichat, APHP Saint-Antoine, Bordeaux Pellegrin, Lyon Edouard Herriot, CHR ORLEANS, Nice CHU, Cabinet Bièvres, CHU POITIERS, OUEST PATHOLOGIE, DIAG (Nice), GRP 2 RIVES, HPL, Centre François Baclesse Luxembourg, CHU ESTAIN , MEDIPATH (Toulon)

File number
Type : Free value	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : Yes
Description : The unique file number the patient has in his centre

Birth date
Type : Free value	Content : DATE	Mandatory : Yes	Multiple values : No	Unique : No
Description : The patient's birth date

Sex
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : The patient's gender
Possible values : Female, Male

Creation date patient
Type : Free value	Content : DATE	Mandatory : Yes	Multiple values : No	Unique : No
Description : The date when the patient has been created in the database

Significant previous history
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description : No: no significant previous historyNF1: presence of neurofibromatosis type 1 or Recklinghausen diseaseNF2: presence of neurofibromatosis type 2Radiation therapy: tumour developed in a previously radiated areaLymphoedema: tumour developed on a preexisting lymphoedemaGardner: presence of a Gardner syndromLi Fraumeni: presence of a Li Fraumeni diseasePrevious cancer: the patient has previously developed another cancer different from the current tumourOther: other significant previous history with a possible link with the current tumour
Possible values : No, Previous cancer, NF1, NF2, Gardner syndrome, Li Fraumeni syndrome, Retinoblastoma syndrome, Immunodepressed - HIV, Immunodepressed - other, Ollier disease, Maffucci syndrome, Paget disease, Multiple osteochondromas, McCune-Albright syndrome, Rothmund-Thomson syndrome, Werner syndrome, Cherubism, Other genetic disease, Other, Unknown, Familial GISTs, Stratiakis-Carney dyad, Carney Triad, Other malignancy in family

Significant previous history detail
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

Other cancer
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Has the patient another cancer
Possible values : Yes, No, Unknown

Date of last contact
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of the last follow up evaluation or date of death

Lost of follow-up
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Lost of follow-up
Possible values : No, Yes

Vital status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Vital status at last contact
Possible values : Alive, Dead

Cause of death
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Cause of death
Possible values : - Dead of this cancer - Primary cancer - Metastatic disease - Dead of other cancer - Dead of treatment complication - Dead of other cause - Unknown

Date of death
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

Quality control Conticabase
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

Date of control
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

Primary tumour (56 items)

Type of tumour
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : point de départ du développement de la tumeur
Possible values : Soft tissue, Viscera, Bone

Site of tumour
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : No
Description : Site of tumour according to the scroll menu
Possible values : - Soft tissue - Head and neck - Superficial areas of head - Sinus and nasal fossa - Deep facial areas - Orbit - Anterior skull base - Ear - lateral skull base and nasoharynx - Oral cavity - oropharynx - Larynx - trachea - Visceral space of the neck - Neck NOS - Other - Trunk wall - Chest wall - Axilla - Abdominal wall - Trunk - paraspinal - Buttock - Groin - Internal trunk - Retroperitoneum - Peritoneum - Pelvis - Thorax internal - Large vessels - Paratesticular - Lower limb - Thigh - Knee - Leg - Ankle - Foot - Toe - Upper limb - Shoulder girdle - Upper arm - Elbow - Forearm - Wrist - Hand - Finger - Viscera - Gastro Intestinal tractus - Oesophagus - Stomach - Duodenum - Appendix - Small intestine - Colon - Rectum - Anus - Gyneacological area - Uterus - Ovary - Fallopian tube - Vagina - Vulva - Others - Breast - Lung - Heart - Pleura - Thymus - Thyroid - Kidney - Bladder - Ureter - Prostate - Testis - Epididymis - Penis - Spleen - Liver - Pancreas - Gallbladder - Salivary gland - Tonsil - Adrenal - Brain - Meninges - Lymph node - Bone - Skull and face bone - Skull NOS - Ethmoid - Superior maxilla - Mandible - Bone face - Upper airways - Larynx - Bronchus - Nasal septum - Spine - Cervical spine - Dorsal spine - Lumbar spine - Basin, sacrum, coccyx - Basin - Sacrum - Coccyx - Hip joint - Other thoracic bone - Rib - Sternum - Clavicle - Superior limb and shoulder - Bone shoulder girdle - Scapula - Shoulder joint - Humerus - Elbow joint - Ulna - Radius - Wirst joint - Hand bone NOS - Carpal (Hand) - Metacarpals (Hand) - Hand phalanges - Hand joint - Inferior limb - Femur - Patella - Knee joint - Tibia - Fibula - Ankle joint - Bone foot NOS - Tarsals (Foot) - Metatarsals (Foot) - Foot phalanges - Foot joint

Side (RESOS)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Laterality of bone tumour in human body
Possible values : Left, Right, Median, Unspecified, Not applicable

Size of tumour (mm)
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Largest diameter of the tumour expressed in mm

Depth of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Superficial: the tumour is located above the superficial aponeurosis with no involvement of this aponeurosis Deep: the tumour is located beneath the superficial aponeurosis with no involvement of the area above this aponeurosis. Involvement of the aponeurosis is possibleSuperficial and deep: the tumour is located above and beneath the superficial aponeurosis
Possible values : Superficial, Superficial and deep, Deep, Surface, Cortical, Intra-medullary

Histotype
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Histotype of the primary tumour to be chosen in the scroll menu (2013 WHO classification, 0)
Possible values : - Benign lesion - Benign adipocytic tumours - Angiolipoma - Angiomyolipoma - Chondroid lipoma - Hibernoma - Lipoblastoma/lipoblastomatosis - Lipoma - Lipomatosis - Lipomatosis of nerve - Atypical spindle cell/pleomorphic lipomatous tumour - Myelolipoma - Myolipoma - Spindle cell / pleomorphic lipoma - Benign chondrogenic tumours - Chondroblastoma NOS - Chondroma - Chondromyxoid fibroma - Enchondroma - Osteochondroma - Osteochondromyxoma - Periosteal chondroma - Pulmonary chondroma - Pulmonary hamartoma - Subungueal exostosis - Synovial chondromatosis - Benign fibroblastic/myofibroblastic tumours - Adenofibroma - Angiofibroma - Angiomyofibroblastoma - Calcifying aponeurotic fibroma - Calcifying fibrous tumour - Cellular angiofibroma - Desmoplastic fibroblastoma - Elastofibroma - Fasciitis - Fibroblastic tumour with SMAD3 fusion - Fibrochondromyxoid tumour with THBS1 fusion - Fibro-osseous pseudotumour of digits - Fibroma of tendon sheath - Fibromatosis colli - Fibrous hamartoma of infancy - Gardner fibroma - Inclusion body fibromatosis - Intra-nodal palisaded myofibroblastoma - Ischaemic fasciitis - Juvenile hyaline fibromatosis - Myofibroblastoma - Myositis ossificans - Nasopharyngeal angiofibroma - Nodular fasciitis - Nuchal-type fibroma - Organ-associated pseudosarcomatous myofibroblastic proliferations - Other fibromas - Proliferative fasciitis - Proliferative myositis - Benign fibro-histiocytic tumours - Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws) - Deep benign fibrous histiocytoma - Epithelioid fibrous histiocytoma - Erdheim-Chester disease - Fibrous histiocytoma - Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma) - Langerhans cell histiocytosis - Non Ossifying fibroma - Rosai-Dorfman disease - Tenosynovial giant cell tumour NOS - Tenosynovial giant cell tumour, diffuse type - Tenosynovial giant cell tumour, localized type - Benign nerve sheath tumours - Atypical neurofibromatous neoplasm of uncertain biological potential ANNUBP - Benign Triton tumour - Dermal nerve sheath myxoma - Ectopic meningioma - Granular cell tumour - Hybrid nerve sheath tumours - Nasal glial heterotopia - Neurofibroma - Neurothekeoma - Perineurioma - Plexiform neurofibroma - Schwannoma - Solitary circumscribed neuroma - Benign notochordal tumour - Benign osteogenic tumours - Osteoid osteoma - Osteoma - Benign pericytic tumours - Angioleiomyoma - Glomus tumour - Myofibroma / myofibromatosis - Myopericytoma - Benign skeletal muscle tumours - Rhabdomyoma - Rhabdomyoma - adult type - Rhabdomyoma - fetal type - Rhabdomyoma - genital type - Benign smooth muscle tumours - Atypical polypoid adenomyoma - Adenomyoma - Bizarre nuclei leiomyoma - Cellular leiomyoma - Diffuse leiomyomatosis - Dissecans leiomyoma - Epithelioid leiomyoma - Intraveinous leiomyomatosis - Leiomyoma - Leiomyomatosis peritonealis disseminata - Mitotically-active leiomyoma - Myxoid leiomyoma - Benign tumours of uncertain differentiation - Acral fibromyxoma - Brown tumour - Deep (aggressive) angiomyxoma - Ectopic hamartomatous thymoma - Fibrous dysplasia - Inflammatory fibroid polyp - Intramuscular myxoma - Myxoma NOS - Osteofibrous dysplasia - Pleomorphic hyalinizing angiectatic tumour - Pleuropulmonary blastoma - Simple bone cyst - Superficial angiomyxoma - Benign vascular tumours - Angiolymphoid hyperplasia - Angiomatosis - Atypical vascular lesion - Diffuse pulmonary lymphangiomatosis - Epithelioid hemangioma - Gorham disease - Hemangioma - Intra-muscular hemangioma - Lymphangioma NOS - Lymphangiomatosis - Pyogenic granuloma - Osseous pseudo-tumours - Bizarre parosteal osteochondromatous proliferation - Callus - Florid ossificans periostitis - Post-traumatic fibro-osseous lesion - Tophaceous pseudogout - Other benign lesion - GIST - gastrointestinal stromal tumour (GIST), low, very low risk - gastrointestinal stromal tumour (GIST), intermediate risk - gastrointestinal stromal tumour (GIST), high risk - Non-mesenchymal malignant tumour - Carcinoma - Germinal tumor - Lymphoma - Melanoma - Myeloma - Other non-mesenchymal malignant tumours - Plasmocytoma - Other diagnoses - Diagnosis unspecified - Undifferentiated malignant tumour - Sarcoma - Chondrosarcoma - Central chondrosarcoma - Chondrosarcoma, grade 1 - Chondrosarcoma, grade 2 - Chondrosarcoma, grade 3 - Chondrosarcoma NOS - Clear cell chondrosarcoma - Dedifferentiated chondrosarcoma - Mesenchymal chondrosarcoma - Periosteal chondrosarcoma - Peripheral chondrosarcoma - Leiomyosarcoma - Leiomyosarcoma - differentiated - Leiomyosarcoma - epithelioid - Leiomyosarcoma - myxoid - Leiomyosarcoma - poorly-differentiated - Liposarcoma - Liposarcoma - dedifferentiated - Liposarcoma - mixed type - Liposarcoma - myxoid - Liposarcoma - NOS - Liposarcoma - pleomorphic - Liposarcoma - round cell - Liposarcoma - well differentiated - Myxoid pleomorphic liposarcoma - Malignant fibrohistiocytic tumours of bone - Malignant giant cell tumour of bone - Malignant peripheral nerve sheath tumour - Ectomesenchymoma - Malignant perineurioma - Malignant Triton tumour - MPNST - epithelioid type - MPNST - usual type - Miscellaneous sarcomas - Alveolar soft part sarcoma - Angiosarcoma - BCOR sarcoma - CIC-DUX sarcoma - CIC-rearranged sarcoma - Clear cell sarcoma - Desmoplastic round cell tumour - Epithelioid hemangioendothelioma NOS - Epithelioid hemangioendothelioma with TFE3 fusion - Epithelioid hemangioendothelioma with WWTR1 fusion - Epithelioid sarcoma - Ewing sarcoma - Extraskeletal myxoid chondrosarcoma - Fibrosarcoma NOS - High risk solitary fibrous tumour - Intimal sarcoma - Low grade fibromyxoid sarcoma - Low grade sinonasal sarcoma - Malignant glomus tumour - Malignant granular cell tumour - Malignant mesenchymoma - Malignant mixed tumor - Malignant myoepithelial tumour - Malignant ossifying fibromyxoid tumour - Malignant PECOMA - Malignant rhabdoid tumour - Malignant tenosynovial giant cell tumour - Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion - Sclerosing epithelioid fibrosarcoma - SMARCA4-deficient undifferentiated thoracic tumour - Myxofibrosarcoma - Osteosarcoma - Conventional osteosarcoma - Dedifferentiated low-grade central osteosarcoma - Dedifferentiated parosteal osteosarcoma - Extraskeletal osteosarcoma - High-grade surface osteosarcoma - Low-grade central osteosarcoma - Osteoblastoma-like osteosarcoma - Osteosarcoma NOS - Parosteal osteosarcoma - Periosteal osteosarcoma - Small cell osteosarcoma - Secondary osteosarcoma - Telangiectasic osteosarcoma - Other sarcomas - Adamantinoma - Adenosarcoma - Chondroid chordoma - Chordoma NOS - Dedifferentiated adamantimoma - Dedifferentiated chordoma - Endometrial stromal sarcoma - Endometrial stromal sarcoma - high-grade - Endometrial stromal sarcoma - low-grade - Phyllodes sarcoma - Poorly differenciated chordoma - Undifferentiated uterine sarcoma - Rhabdomyosarcoma - Adult spindle cell rhabdomyosarcoma - Alveolar rhabdomyosarcoma - Embryonal rhabdomyosarcoma - botryoid type - Embryonal rhabdomyosarcoma - NOS - Embryonal rhabdomyosarcoma - spindle cell type - Embryonal rhabdomyosarcoma - usual type - Pleomorphic rhabdomyosarcoma - Rhabdomyosarcoma - NOS - Rhabdomyosarcoma with MYOD1 mutation - Rhabdomyosarcoma with TFCP2 fusion - Rhabdomyosarcoma with VGLL2/NCOA2 fusion - Sclerosing rhabdomyosarcoma - Spindle cell rhabdomyosarcoma - Suspicion of sarcoma - Synovial sarcoma - Synovial sarcoma - biphasic - Synovial sarcoma - monophasic - Synovial sarcoma - NOS - Synovial sarcoma - poorly differentiated - Undifferentiated sarcoma - Undifferentiated epithelioid sarcoma - Undifferentiated pleomorphic sarcoma - Undifferentiated round cell sarcoma - Undifferentiated sarcoma - NOS - Undifferentiated spindle cell sarcoma - Tumour of intermediate malignancy - Atypical lipomatous tumour - Intermediate chondrogenic tumours - Atypical cartilaginous tumour - Cartilaginous tumour of uncertain prognosis - Chondromatosis NOS - Intermediate fibroblastic/myofibroblastic tumours - Dermatofibrosarcoma protuberans - Desmoid-type fibromatosis - Desmoplastic fibroma of bone - Fibro-osseous tumour of bone NOS - Fibrosarcomatous dermatofibrosarcoma protuberans - Giant cell fibroblastoma - Infantile fibrosarcoma - Inflammatory myofibroblastic tumour - Intermediate risk solitary fibrous tumour - Lipofibromatosis - Low grade myofibroblastic sarcoma - Low risk solitary fibrous tumour - Myxoinflammatory fibroblastic sarcoma - NTRK-rearranged spindle cell neoplasm - Palmar/plantar fibromatosis - Superficial CD34-positive fibroblastic tumour - Intermediate fibrohistiocytic tumours - Giant cell tumour of bone - Giant cell tumour of soft tissues - Metastatic giant cell tumour of bone - Osseous tumour rich in giant cell NOS - Plexiform fibrohistiocytic tumour - Suspicion of giant cell tumour of bone - Intermediate osteogenic tumours - Osteoblastoma NOS - Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma) - Intermediate peripheral nerve sheath tumour - Malignant melanotic neural tumour - Intermediate tumours of uncertain differentiation - Aneurysmal bone cyst - Angiomatoid fibrous histiocytoma - Atypical fibroxanthoma - Cutaneous pleomorphic sarcoma - Hemosiderotic fibrolipomatous tumour - Lymphangioleiomyoma/lymphangioleiomyomatosis - Malignant phosphaturic mesenchymal tumour - Melanotic neuroectodermal tumour of infancy - Mesenchymal tumor with GLI1 alteration - Mixed tumour - Myoepithelioma - Ossifying fibromyxoid tumour - PECOMA - NOS - Phosphaturic mesenchymal tumour NOS - Intermediate vascular tumours - Composite hemangioendothelioma - Epithelioid vascular tumour of bone NOS - Kaposi sarcoma - Kaposiform hemangioendothelioma - Papillary intralymphatic angioendothelioma - Pseudomyogenic hemangioendothelioma - Retiform hemangioendothelioma - Other tumours of intermediate malignancy - Atypical smooth muscle tumour - EBV-associated smooth muscle tumour (STUMP) - Endometrial stromal nodule - Endometrial stromal tumor low-grade - Inflammatory rhabdomyoblastic tumour - Metastatic leiomyoma - Smooth muscle tumour of undetermined malignant potential (STUMP) - Uterine tumour resembling ovarian sex cord tumours (UTROSCT) - Other intermediate mesenchymal tumour of bone - Mesenchymoma NOS - Osteofibrous dysplasia-like adamantinoma

Date of original diagnosis
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of the first sampling which allowed the diagnosis of the current tumour

Age at diagnosis
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description :

Diagnosis changed
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Modification de diagnostic (diagnostic redressé) suite à la relecture anapath. Exemple : en 2010 diagnostic de lipome relecture des lames en 2013 diagnostic de liposarcome le diagnostic est redressé donc Diagnosis changed = Yes. Exemple : diagnostic liposarcome bien différencié qui devient après rechute un liposarcome indifférentié. Diagnosis changed = No.
Possible values : No, Yes

Initial diagnosis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Quel était le diagnostic avant que le redressement de diag ?
Possible values : - Benign lesion - Benign adipocytic tumours - Angiolipoma - Angiomyolipoma - Chondroid lipoma - Hibernoma - Lipoblastoma/lipoblastomatosis - Lipoma - Lipomatosis - Lipomatosis of nerve - Atypical spindle cell/pleomorphic lipomatous tumour - Myelolipoma - Myolipoma - Spindle cell / pleomorphic lipoma - Benign chondrogenic tumours - Chondroblastoma NOS - Chondroma - Chondromyxoid fibroma - Enchondroma - Osteochondroma - Osteochondromyxoma - Periosteal chondroma - Pulmonary chondroma - Pulmonary hamartoma - Subungueal exostosis - Synovial chondromatosis - Benign fibroblastic/myofibroblastic tumours - Adenofibroma - Angiofibroma - Angiomyofibroblastoma - Calcifying aponeurotic fibroma - Calcifying fibrous tumour - Cellular angiofibroma - Desmoplastic fibroblastoma - Elastofibroma - Fasciitis - Fibroblastic tumour with SMAD3 fusion - Fibrochondromyxoid tumour with THBS1 fusion - Fibro-osseous pseudotumour of digits - Fibroma of tendon sheath - Fibromatosis colli - Fibrous hamartoma of infancy - Gardner fibroma - Inclusion body fibromatosis - Intra-nodal palisaded myofibroblastoma - Ischaemic fasciitis - Juvenile hyaline fibromatosis - Myofibroblastoma - Myositis ossificans - Nasopharyngeal angiofibroma - Nodular fasciitis - Nuchal-type fibroma - Organ-associated pseudosarcomatous myofibroblastic proliferations - Other fibromas - Proliferative fasciitis - Proliferative myositis - Benign fibro-histiocytic tumours - Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws) - Deep benign fibrous histiocytoma - Epithelioid fibrous histiocytoma - Erdheim-Chester disease - Fibrous histiocytoma - Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma) - Langerhans cell histiocytosis - Non Ossifying fibroma - Rosai-Dorfman disease - Tenosynovial giant cell tumour NOS - Tenosynovial giant cell tumour, diffuse type - Tenosynovial giant cell tumour, localized type - Benign nerve sheath tumours - Atypical neurofibromatous neoplasm of uncertain biological potential ANNUBP - Benign Triton tumour - Dermal nerve sheath myxoma - Ectopic meningioma - Granular cell tumour - Hybrid nerve sheath tumours - Nasal glial heterotopia - Neurofibroma - Neurothekeoma - Perineurioma - Plexiform neurofibroma - Schwannoma - Solitary circumscribed neuroma - Benign notochordal tumour - Benign osteogenic tumours - Osteoid osteoma - Osteoma - Benign pericytic tumours - Angioleiomyoma - Glomus tumour - Myofibroma / myofibromatosis - Myopericytoma - Benign skeletal muscle tumours - Rhabdomyoma - Rhabdomyoma - adult type - Rhabdomyoma - fetal type - Rhabdomyoma - genital type - Benign smooth muscle tumours - Atypical polypoid adenomyoma - Adenomyoma - Bizarre nuclei leiomyoma - Cellular leiomyoma - Diffuse leiomyomatosis - Dissecans leiomyoma - Epithelioid leiomyoma - Intraveinous leiomyomatosis - Leiomyoma - Leiomyomatosis peritonealis disseminata - Mitotically-active leiomyoma - Myxoid leiomyoma - Benign tumours of uncertain differentiation - Acral fibromyxoma - Brown tumour - Deep (aggressive) angiomyxoma - Ectopic hamartomatous thymoma - Fibrous dysplasia - Inflammatory fibroid polyp - Intramuscular myxoma - Myxoma NOS - Osteofibrous dysplasia - Pleomorphic hyalinizing angiectatic tumour - Pleuropulmonary blastoma - Simple bone cyst - Superficial angiomyxoma - Benign vascular tumours - Angiolymphoid hyperplasia - Angiomatosis - Atypical vascular lesion - Diffuse pulmonary lymphangiomatosis - Epithelioid hemangioma - Gorham disease - Hemangioma - Intra-muscular hemangioma - Lymphangioma NOS - Lymphangiomatosis - Pyogenic granuloma - Osseous pseudo-tumours - Bizarre parosteal osteochondromatous proliferation - Callus - Florid ossificans periostitis - Post-traumatic fibro-osseous lesion - Tophaceous pseudogout - Other benign lesion - GIST - gastrointestinal stromal tumour (GIST), low, very low risk - gastrointestinal stromal tumour (GIST), intermediate risk - gastrointestinal stromal tumour (GIST), high risk - Non-mesenchymal malignant tumour - Carcinoma - Germinal tumor - Lymphoma - Melanoma - Myeloma - Other non-mesenchymal malignant tumours - Plasmocytoma - Other diagnoses - Diagnosis unspecified - Undifferentiated malignant tumour - Sarcoma - Chondrosarcoma - Central chondrosarcoma - Chondrosarcoma, grade 1 - Chondrosarcoma, grade 2 - Chondrosarcoma, grade 3 - Chondrosarcoma NOS - Clear cell chondrosarcoma - Dedifferentiated chondrosarcoma - Mesenchymal chondrosarcoma - Periosteal chondrosarcoma - Peripheral chondrosarcoma - Leiomyosarcoma - Leiomyosarcoma - differentiated - Leiomyosarcoma - epithelioid - Leiomyosarcoma - myxoid - Leiomyosarcoma - poorly-differentiated - Liposarcoma - Liposarcoma - dedifferentiated - Liposarcoma - mixed type - Liposarcoma - myxoid - Liposarcoma - NOS - Liposarcoma - pleomorphic - Liposarcoma - round cell - Liposarcoma - well differentiated - Myxoid pleomorphic liposarcoma - Malignant fibrohistiocytic tumours of bone - Malignant giant cell tumour of bone - Malignant peripheral nerve sheath tumour - Ectomesenchymoma - Malignant perineurioma - Malignant Triton tumour - MPNST - epithelioid type - MPNST - usual type - Miscellaneous sarcomas - Alveolar soft part sarcoma - Angiosarcoma - BCOR sarcoma - CIC-DUX sarcoma - CIC-rearranged sarcoma - Clear cell sarcoma - Desmoplastic round cell tumour - Epithelioid hemangioendothelioma NOS - Epithelioid hemangioendothelioma with TFE3 fusion - Epithelioid hemangioendothelioma with WWTR1 fusion - Epithelioid sarcoma - Ewing sarcoma - Extraskeletal myxoid chondrosarcoma - Fibrosarcoma NOS - High risk solitary fibrous tumour - Intimal sarcoma - Low grade fibromyxoid sarcoma - Low grade sinonasal sarcoma - Malignant glomus tumour - Malignant granular cell tumour - Malignant mesenchymoma - Malignant mixed tumor - Malignant myoepithelial tumour - Malignant ossifying fibromyxoid tumour - Malignant PECOMA - Malignant rhabdoid tumour - Malignant tenosynovial giant cell tumour - Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion - Sclerosing epithelioid fibrosarcoma - SMARCA4-deficient undifferentiated thoracic tumour - Myxofibrosarcoma - Osteosarcoma - Conventional osteosarcoma - Dedifferentiated low-grade central osteosarcoma - Dedifferentiated parosteal osteosarcoma - Extraskeletal osteosarcoma - High-grade surface osteosarcoma - Low-grade central osteosarcoma - Osteoblastoma-like osteosarcoma - Osteosarcoma NOS - Parosteal osteosarcoma - Periosteal osteosarcoma - Small cell osteosarcoma - Secondary osteosarcoma - Telangiectasic osteosarcoma - Other sarcomas - Adamantinoma - Adenosarcoma - Chondroid chordoma - Chordoma NOS - Dedifferentiated adamantimoma - Dedifferentiated chordoma - Endometrial stromal sarcoma - Endometrial stromal sarcoma - high-grade - Endometrial stromal sarcoma - low-grade - Phyllodes sarcoma - Poorly differenciated chordoma - Undifferentiated uterine sarcoma - Rhabdomyosarcoma - Adult spindle cell rhabdomyosarcoma - Alveolar rhabdomyosarcoma - Embryonal rhabdomyosarcoma - botryoid type - Embryonal rhabdomyosarcoma - NOS - Embryonal rhabdomyosarcoma - spindle cell type - Embryonal rhabdomyosarcoma - usual type - Pleomorphic rhabdomyosarcoma - Rhabdomyosarcoma - NOS - Rhabdomyosarcoma with MYOD1 mutation - Rhabdomyosarcoma with TFCP2 fusion - Rhabdomyosarcoma with VGLL2/NCOA2 fusion - Sclerosing rhabdomyosarcoma - Spindle cell rhabdomyosarcoma - Suspicion of sarcoma - Synovial sarcoma - Synovial sarcoma - biphasic - Synovial sarcoma - monophasic - Synovial sarcoma - NOS - Synovial sarcoma - poorly differentiated - Undifferentiated sarcoma - Undifferentiated epithelioid sarcoma - Undifferentiated pleomorphic sarcoma - Undifferentiated round cell sarcoma - Undifferentiated sarcoma - NOS - Undifferentiated spindle cell sarcoma - Tumour of intermediate malignancy - Atypical lipomatous tumour - Intermediate chondrogenic tumours - Atypical cartilaginous tumour - Cartilaginous tumour of uncertain prognosis - Chondromatosis NOS - Intermediate fibroblastic/myofibroblastic tumours - Dermatofibrosarcoma protuberans - Desmoid-type fibromatosis - Desmoplastic fibroma of bone - Fibro-osseous tumour of bone NOS - Fibrosarcomatous dermatofibrosarcoma protuberans - Giant cell fibroblastoma - Infantile fibrosarcoma - Inflammatory myofibroblastic tumour - Intermediate risk solitary fibrous tumour - Lipofibromatosis - Low grade myofibroblastic sarcoma - Low risk solitary fibrous tumour - Myxoinflammatory fibroblastic sarcoma - NTRK-rearranged spindle cell neoplasm - Palmar/plantar fibromatosis - Superficial CD34-positive fibroblastic tumour - Intermediate fibrohistiocytic tumours - Giant cell tumour of bone - Giant cell tumour of soft tissues - Metastatic giant cell tumour of bone - Osseous tumour rich in giant cell NOS - Plexiform fibrohistiocytic tumour - Suspicion of giant cell tumour of bone - Intermediate osteogenic tumours - Osteoblastoma NOS - Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma) - Intermediate peripheral nerve sheath tumour - Malignant melanotic neural tumour - Intermediate tumours of uncertain differentiation - Aneurysmal bone cyst - Angiomatoid fibrous histiocytoma - Atypical fibroxanthoma - Cutaneous pleomorphic sarcoma - Hemosiderotic fibrolipomatous tumour - Lymphangioleiomyoma/lymphangioleiomyomatosis - Malignant phosphaturic mesenchymal tumour - Melanotic neuroectodermal tumour of infancy - Mesenchymal tumor with GLI1 alteration - Mixed tumour - Myoepithelioma - Ossifying fibromyxoid tumour - PECOMA - NOS - Phosphaturic mesenchymal tumour NOS - Intermediate vascular tumours - Composite hemangioendothelioma - Epithelioid vascular tumour of bone NOS - Kaposi sarcoma - Kaposiform hemangioendothelioma - Papillary intralymphatic angioendothelioma - Pseudomyogenic hemangioendothelioma - Retiform hemangioendothelioma - Other tumours of intermediate malignancy - Atypical smooth muscle tumour - EBV-associated smooth muscle tumour (STUMP) - Endometrial stromal nodule - Endometrial stromal tumor low-grade - Inflammatory rhabdomyoblastic tumour - Metastatic leiomyoma - Smooth muscle tumour of uncertain malignant potential (STUMP) - Smooth muscle tumour of undetermined malignant potential (STUMP) - Uterine tumour resembling ovarian sex cord tumours (UTROSCT) - Other intermediate mesenchymal tumour of bone - Mesenchymoma NOS - Osteofibrous dysplasia-like adamantinoma

Date of review
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date à laquelle la relecture anapath a permis de redresser le diagnostic.

Grade of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Histologic grade of the primary tumour according to the French grading system: tumour differentiation score 1 to 3, 0) + mitotic index (score 1 to 3, 0) + tumour necrosis (score 0 to 2, 0) Grade=1 for total score of 2 or 3 Grade=2 for total score of 4 or 5 Grade=3 for total score of 6, 7 or 8
Possible values : 1, 2, 3, NA

Mitotic Index / 50HPF
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description :

Miettinen/AFIP
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Risque de malignité des GIST selon Miettinen
Possible values : Very low risk, Low risk, Intermediate risk, High risk, NA

Radiation area
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : tumour developed in a previously irradiated area
Possible values : No, Yes

Lymphoedema
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : tumour developed in a region with a preexisting lymphoedema
Possible values : No, Yes

Loco-regional extension
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description : Tumour invasion of healthy adjacent tissues (NB: a deep intramuscular tumour systematically invades the adjacent muscle)
Possible values : No, Dermis, Hypodermis, Vasculo-nervous, Bone, Muscle, Adjacent organ

Multifocal tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : No: when tumour is only one entity Yes: when tumour is one entity associated with one or more nodules
Possible values : No, Yes

N
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes when there is a locoregional lymph node involvement detected by clinical and/or imaging evaluation
Possible values : No, Yes

M
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes when there is a distant metastasis diagnosed by imaging and / or histological evaluation
Possible values : Yes, No, Skip

StatusAtReferral
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : First event, Relapse

TTTBeforeReferral
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

Performance status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : 0 Fully active, able to carry out all pre-disease performance without restriction1 (Restricted) impairment in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work2 Ambulatory and capable of all selfcare but unable to carry out any work activities for more than 50% of waking hours3 Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours4 Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair
Possible values : 0, 1, 2, 3, 4, NA

Cancer status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Cancer status at last contact
Possible values : No evidence of this cancer, Evidence of this cancer, Unknown, Not Applicable

ImagingBeforeTTT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : No, Ultrasound, CT Scan, MRI, X-Ray (standard radiograph), Other, Not available

PathoFracture
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

Surgery of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes, Curettage

Date of surgery
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of surgery

Time of surgery
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : First, Second, Third

Type of surgery of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Excision: removal of the tumour with no normal tissue at least of the surface of the tumour Wide resection: removal of the tumour with normal tissue covering all the surface of the tumour Compartimentectomy: removal of the tumour with all the tissues contained in an anatomical compartiment Amputation (of a limb or of the distal part of a limb such as a hand, foot or finger, 0)
Possible values : Excision, Wide resection, Compartimentectomy, Amputation

Surgeon
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Chirurgien qui a opéré la tumeur primaire Les chirurgiens Sarcome sont listés dans Network. Si la RCP propose que l'opération soit faite par un chirurgien particulier qui ne fait pas parti du réseau mais dont le nom est donné lors de la RCP il doit être saisi dans Referral to a specialized surgery outside network. Si le chirurgien ne correspond pas aux situations précédentes alors saisir Outside network.

Re-excision
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Reprise chirurgicale tumeur primaire Ne sont prises en compte que les reprises chirurgicales ayant lieu avant la progression ou la rechute.
Possible values : No, Yes, Curettage

Re-excision surgeon
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Chirurgien qui a ré-opéré la tumeur primaire Les chirurgiens sarcome sont listés dans Network. Si la RCP propose que la reprise soit faite par un chirurgien particulier qui ne fait pas parti du réseau mais dont le nom est donné lors de la RCP il doit être saisi dans Referral to a specialized surgery outside network. Si le chirurgien ne correspond pas aux situations précédentes alors saisir Outside network.

Tumour spillage (CTCB)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Expert pathologist observed if the tumour was spilt
Possible values : Yes, No

Margin R
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : R0: complete tumour resection at the macroscopic (surgeon, 0) and histological (pathologist, 0) levels R1: complete tumour resection at the macroscopic level (surgeon, 0) with tumour cells on the margins at the histological examination If the tumour is seen by the surgeon, it should be classified as R1. For most retroperitoneal tumours, the resection is R1. R2: incomplete tumour resection at the macroscopic level (surgeon, 0)
Possible values : R0, R1, R2, Not evaluable

ResidualTCells
Type : Free value	Content : PERCENTAGE	Mandatory : No	Multiple values : No	Unique : No
Description :

BoneReconstruction
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Prosthesis, Autograft, Biomaterials

ComplicationSurgery
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Henderson 1, Henderson 2, Henderson 3, Henderson 4

Isolated limb perfusion
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Isolated limb perfusion
Possible values : No, Yes

DILP
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

SystemicTTT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

DSytTTTStart
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

DSystTTTEnd
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

IndicSystTTT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Neo-adjuvant, Adjuvant, Neo-adjuvant and adjuvant, Palliative, Not available

Radiotherapy of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : No: no radiotherapy for the primary tumour First: radiotherapy has been the first treatment performed Second: radiotherapy has been performed after another treatment such as surgery
Possible values : No, First, Second, Third, Palliative

DRTEStart
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

DRTEEnd
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

Dose of radiotherapy
Type : Free value	Content : DECIMAL	Mandatory : No	Multiple values : No	Unique : No
Description : Total dose of radiotherapy given to the entity and expressed in Grays

Hormonotherapy
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: when the patient was treated by hormonotherapy
Possible values : No, Yes

DHormonoTStart
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

AINS
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: when the patient was treated by AINS
Possible values : No, Yes

DAINSStart
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

OtherTTT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : No, Radiofrequency, Cryotherapy, Embolisation, Other

Clinical trial
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour
Possible values : No, Yes

Locoregional control
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : no residual tumour at the primary site by clinical and imaging examinations
Possible values : Yes, No, Not available

Complete remission after treatment
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : There is no evidence of residual tumour at the end of treatment of the tumour by clinical (and imaging when performed, 0) evaluation.
Possible values : Yes, No

Local recurrence (38 items)

Rank of local recurrence
Type : Free value	Content : INTEGER	Mandatory : Yes	Multiple values : No	Unique : No
Description : Rank of local recurrence

Date of local recurrence
Type : Free value	Content : DATE	Mandatory : Yes	Multiple values : No	Unique : No
Description : Date of diagnosis of the first local recurrence

Size of tumour (mm)
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Largest diameter of the tumour expressed in mm

Depth of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Superficial: the tumour is located above the superficial aponeurosis with no involvement of this aponeurosis Deep: the tumour is located beneath the superficial aponeurosis with no involvement of the area above this aponeurosis. Involvement of the aponeurosis is possibleSuperficial and deep: the tumour is located above and beneath the superficial aponeurosis
Possible values : Superficial, Superficial and deep, Deep, Surface, Cortical, Intra-medullary

Multifocal tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : No: when tumour is only one entity Yes: when tumour is one entity associated with one or more nodules
Possible values : No, Yes

Radiation area
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : tumour developed in a previously irradiated area
Possible values : No, Yes

Performance status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : 0 Fully active, able to carry out all pre-disease performance without restriction1 (Restricted) impairment in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work2 Ambulatory and capable of all selfcare but unable to carry out any work activities for more than 50% of waking hours3 Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours4 Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair
Possible values : 0, 1, 2, 3, 4, NA

PathoFracture
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

Surgery of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes, Curettage

Date of surgery
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of surgery

Time of surgery
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : First, Second, Third

Type of surgery of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Excision: removal of the tumour with no normal tissue at least of the surface of the tumour Wide resection: removal of the tumour with normal tissue covering all the surface of the tumour Compartimentectomy: removal of the tumour with all the tissues contained in an anatomical compartiment Amputation (of a limb or of the distal part of a limb such as a hand, foot or finger, 0)
Possible values : Excision, Wide resection, Compartimentectomy, Amputation

SurgeonLR
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Network, Outside Network

Re-excision
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Reprise chirurgicale tumeur primaire Ne sont prises en compte que les reprises chirurgicales ayant lieu avant la progression ou la rechute.
Possible values : No, Yes, Curettage

ReExcisionSurgeonLR
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Network, Outside Network

Tumour spillage (CTCB)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Expert pathologist observed if the tumour was spilt
Possible values : Yes, No

Margin R
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : R0: complete tumour resection at the macroscopic (surgeon, 0) and histological (pathologist, 0) levels R1: complete tumour resection at the macroscopic level (surgeon, 0) with tumour cells on the margins at the histological examination If the tumour is seen by the surgeon, it should be classified as R1. For most retroperitoneal tumours, the resection is R1. R2: incomplete tumour resection at the macroscopic level (surgeon, 0)
Possible values : R0, R1, R2, Not evaluable

ResidualTCells
Type : Free value	Content : PERCENTAGE	Mandatory : No	Multiple values : No	Unique : No
Description :

BoneReconstruction
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Prosthesis, Autograft, Biomaterials

ComplicationSurgery
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Henderson 1, Henderson 2, Henderson 3, Henderson 4

SystemicTTT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

DSytTTTStart
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

DSystTTTEnd
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

IndicSystTTT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Neo-adjuvant, Adjuvant, Neo-adjuvant and adjuvant, Palliative, Not available

Isolated limb perfusion
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Isolated limb perfusion
Possible values : No, Yes

DILP
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

Radiotherapy of tumour
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : No: no radiotherapy for the primary tumour First: radiotherapy has been the first treatment performed Second: radiotherapy has been performed after another treatment such as surgery
Possible values : No, First, Second, Third, Palliative

DRTEStart
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

DRTEEnd
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

Dose of radiotherapy
Type : Free value	Content : DECIMAL	Mandatory : No	Multiple values : No	Unique : No
Description : Total dose of radiotherapy given to the entity and expressed in Grays

Hormonotherapy
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: when the patient was treated by hormonotherapy
Possible values : No, Yes

DHormonoTStart
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

AINS
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: when the patient was treated by AINS
Possible values : No, Yes

DAINSStart
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

Clinical trial
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour
Possible values : No, Yes

OtherTTT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : No, Radiofrequency, Cryotherapy, Embolisation, Other

Locoregional control
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : no residual tumour at the primary site by clinical and imaging examinations
Possible values : Yes, No, Not available

Complete remission after treatment
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : There is no evidence of residual tumour at the end of treatment of the tumour by clinical (and imaging when performed, 0) evaluation.
Possible values : Yes, No

Metastatic disease (8 items)

Location of first metastasis
Type : Constrained	Content : TEXT	Mandatory : Yes	Multiple values : Yes	Unique : No
Description : Location of first metastasis
Possible values : Bone, Bone marrow, Brain, Liver, Lung, Lymph node, Peritoneum, Pleura, Skin, Soft tissues, Other

Date of first metastasis
Type : Free value	Content : DATE	Mandatory : Yes	Multiple values : No	Unique : No
Description : Date of diagnosis of the first metastasis

Number of metastatic sites
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Number of metastasic sites at diagnosis

Location of further metastasis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description : Location of further metastasis
Possible values : Bone, Bone marrow, Brain, Liver, Lung, Lymph node, Peritoneum, Pleura, Skin, Soft tissues, Other, No

TTTM
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : No, Systemic treatment, Locoregional treatment, AINS, Other

Locoregional treatment of metastasis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description : Choose one or several (CTRL + clic) type(s) of locoregional treatment for the treatment of metastasis
Possible values : Surgery, Radiofrequency, Cryotherapy, Radiotherapy, Other

IndicSystTTT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Neo-adjuvant, Adjuvant, Neo-adjuvant and adjuvant, Palliative, Not available

Clinical trial
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour
Possible values : No, Yes

Sample (18 items)

Sample reference
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : Yes
Description : The sample reference in the center

Date of sampling
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date on which the sample was removed

Metastasis sample location
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Location of this metastasis sample (only for metastasis sample)
Possible values : Bone, Bone marrow, Brain, Liver, Lung, Lymph node, Peritoneum, Pleura, Skin, Soft tissues, Other

Treatment before sampling
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description : No : no treatment of the tumour event before sampling Chemotherapy: the tumour event has been received a chemotherapy before sampling Radiotherapy: radiotherapy on the tumour event before sampling ILP: an isolated limb perfusion procedure has been performed on the tumour event before sampling Other: other treatment has been performed on the tumour event before sampling
Possible values : No, Systemic treatment, Radiotherapy, ILP, Other

Type of sampling
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Microbiopsy: sampling of the tumour with a core needleOpen biopsy: surgical resection of a piece of the tumour with a diagnostic intendTumour resection: surgical resection of the whole tumour
Possible values : Microbiopsy, Open biopsy, Tumour resection, Curettage

Immunohistochemistry
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

FISH
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

Result FISH
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : In progress, Negative, Non interpretable, Positive

Molecular Biology
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Molecular Biology techniques performed
Possible values : No, Yes

Result (Molecular Biology)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : In progress, Negative, Positive, Non interpretable

RNASeq
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Not done, Done non interpretable, Done interpretable

Gene 1
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Fusion transcript gene 1
Possible values : No transcrit, Other, A2M, ABHD12B, AC011523.2, ACBD5, ACSL3, ACSL5, ACTB, ACTN1, ADGRF5, AFAP1, AFF3, AGBL4, AGK, AGTRAP, AHCYL1, AHRR, AKAP13, AKAP9, AKT3, ALK, AMACR, AP3S1, APIP, ARHGAP12, ARID1A, ARID1B, ASPSCR1, ATF1, ATG16L1, ATIC, ATP11B, ATP2B4, ATXN1, AUTS2, BAG4, BAIAP2L1, BCAN, BCAP29, BCL10, BCL2, BCLAF1, BCOR, BCORL1, BCR, BICC1, BIRC3, BMX, BRAF, BRD1, BRD3, BRD4, BRD8, BTBD1, C11orf95, C19MC, C3orf62, C5orf30, CAB39L, CAD, CALML4, CAMTA1, CANT1, CAPZA2, CARMN, CARS, CASP7, CCAR2, CCDC6, CCDC67, CCDC88C, CCNB3, CCND1, CCNH, CD101, CD44, CD63, CD74, CD99L2, CDC27, CDH11, CDH17, CDK5RAP2, CDX1, CEACAM5, CEP128, CEP192, CEP89, CHCHD7, CHD7, CIC, CIITA, CITED1, CITED2, CLCN6, CLDN1, CLIP1, CLIP2, CLN6, CLTC, CNNM3, COL12A1, COL17A1, COL1A, COL1A1, COL1A2, COL3A1, COL6A3, COMMD10, CPG, CPSF6, CREB1, CREB3L1, CREB3L2, CREB3L3, CREBBP, CREBZF, CREM, CRTC1, CRTC3, CSF1, CTB.35F21.1, CTNNA3, CTNNB1, CXCR4, CXorf67, DACH1, DAXX, DCTN1, DDIT3, DDX3X, DDX5, DIP2C, DKKL1, DNAH5, DNAJB6, DST, DTD1, DUS4L, DUX4, DUX4L2, E2F1, EEF1AKMT3, EGF, EGFR, EHBP1, EIF3E, ELF5, ELK4, ELN, EMILIN2, EML4, EMP1, EP300, EP400, EPC1, EPC2, EPS15, ERBB2, ERC1, ERG, ERLIN2, ESR1, ESRP1, EST14, ETV1, ETV2, ETV4, ETV5, ETV6, EWSR1, EZR, FAM131B, FAM227A, FER, FEV, FGF1, FGF2, FGFR1, FGFR2, FGFR3, FHIT, FIP1L1, FLI1, FLJ60017, FN1, FOSB, FOXO1, FOXO4, FOXO6, FOXP1, FOXR1, FUS, GCC2, GCNT3, GIT2, GLI1, GNAI1, GOLGA5, GOLGB1, GOPC, GPN1, GPS2, GREB1, GRIK2, GRM1, GSN, GTF2I, GTF3C2, GUCA2B, HAS2, HBA, HBA2, HBB, HENMT1, HERV-K, HERVK17, HEY1, HIP1, HIPK1, HLA-A, HMGA1, HMGA2, HMGN2P46, HNRNPA2B1, HOOK1, HOOK3, HOXD13, HS6ST2, HSPA8, HTN3, HTT, IG, IGF2, IGFBP5, IGH, IGK, IGL, IKBKG, INO80D, IRF2BP2, IRF4/DUSP22, ITD, JAK2, JAZF1, KANSL1, KAT6B, KCTD7, KDM2A, KDM2B, KDM4B, KHDRB52, KHSRP, KIAA1217, KIAA1549, KIAA1598, KIF5B, KIFC3, KIRREL, KLC1, KLF15, KLF17, KLHL29, KLHL7, KLK2, KMT2A, KRAS, KTN1, LACTB2, LAMTOR1, LIFR, LMAN2L, LMNA, LPP, LRIG3, LRRC31, LRRC34, LRRC59, LRRFIP1, LRRFIP2, LSM14A, LUC7L3, LYN, MAD1L1, MAGI3, MALAT1, MALT1, MAML2, MAML3, MAN2A1, MAP3K8, MBD1, MBTD1, MDK, MEAF6, MECOM, MED12, MEF2C, MEIS1, MELK, MET, MGA, MIPOL1, MIR143HG, MITF, MKL2, MKRN1, MLL, MLL4, MLPH, MPRIP, MSANTD3, MSN, MTOR, MXD1, MYB, MYBL1, MYC, MYH10, MYH9, MYO5A, NAB2, NACC2, NAV2, NCOA1, NCOA2, NCOA3, NCOA4, NCOR2, ND4, NDRG1, NF1, NFASC, NFATC1, NFATC2, NFIA, NFIB, NOL4L, NONO, NOS2, NOTCH1, NOTCH2, NOTCH3, NPC1, NPM1, NR4A3, NRG1, NSD3, NTRK1, NTRK2, NTRK3, NUDCD3, NUMA1, NUP160, NUP214, NUP98, NUTM1, NUTM2A, NUTM2B, NUTM2E, OFD1, OGDH, OMD, PAFAH1B2, PAN3, PAPSS1, PARP14, PATZ1, PAX3, PAX5, PAX7, PAX8, PBX1, PBX3, PDCD1LG2, PDE3B, PDE4DIP, PDE8A, PDGFB, PDGFD, PDGFRA, PDGFRB, PDHX, PDPN, PHF1, PIK3C2A, PITPNC1, PLA2G6, PLAG1, PLIN3, PML, POM121, POU1F1, POU3F1, POU5F1, PPAPDC1A, PPARG, PPFIBP1, PPL, PPP1R1B, PPP6R3, PRB3, PRCC, PRDM10, PRG4, PRKAR1A, PRKCA, PRKCB, PRKCD, PRKD1, PRKDC, PRKG1, PSD2, PSMA8, PTCH1, PTEN, PTMA, PTPRD, PTPRJ, PTPRK, PTPRZ1, PVT1, PWWP2A, QKI, RAB2A, RABGAP1L, RAD51, RAD51B, RAD52, RAF1, RANBP2, RARG, RBM10, RCC1, RELA, RET, RFWD2, RNF13, RNF130, RNF213, ROS1, RP11.57H14.3, RPLP1, RPS11, RRBP1, RREB1, RSPO2, RSPO3, RUNX1, S100A10, SCARB1, SCYL3, SDC4, SEC31A, SEC61G, SERINC1, SERPINE1, SET, SETBP1, SFMBT1, SFPQ, SHH, SLC11A2, SLC12A7, SLC16A7, SLC1A2, SLC26A11, SLC34A2, SLC3A2, SLC43A3, SLC45A2, SLC45A3, SLC5A11, SLC7A14, SMAD2, SMAD3, SMARCA4, SMARCA5, SNAPC3, SND1, SNX19, SOS1, SOX6, SP3, SPATA16, SPECC1L, SPTBN1, SQSTM1, SRF, SS18, SS18L1, SSX1, SSX2, SSX2B, SSX4, STARD3, STAT6, STK32B, STRN, SUZ12, SVIL, TACC1, TACC3, TAF15, TAX1BP1, TBL1XR1, TCEA1, TCF12, TCF4, TCF7L2, TEAD1, TENM4, TERT, TFCP2, TFE3, TFEB, TFG, TGFBR3, THBS1, THRAP3, TIMP3, TLN2, TMEM135, TMPRSS2, TNC, TNS3, TOM1L2, TOP2B, TP53, TP53BP1, TPM1, TPM3, TPM4, TPR, TPRG1, TPTEP1, TRA2B, TRIM11, TRIM24, TRIM27, TRIM33, TRIM4, TRIO, TRIT1, TRMT11, TSFM, TTC17, TTC28, TTYH1, UBE2L3, UBR5, ULK4, USP6, VCL, VGLL2, VGLL3, VGLL4, VIM, VMP1, VTI1A, WDR91, WHSC1L1, WIF1, WT1, WWTR1, YAP1, YWHAE, YY1, ZC3H7B, ZCCHC8, ZFP36, ZFPM2, ZKSCAN1, ZKSCAN5, ZMYM2, ZNF207, ZNF217, ZNF278, ZNF423, ZNF444, ZNF521, ZNF595, ZNF737, ZNF9

Unlisted gene 1
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Fusion transcript unlisted gene 1

Gene 2
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Fusion transcript gene 2
Possible values : No transcrit, Other, A2M, ABHD12B, AC011523.2, ACBD5, ACSL3, ACSL5, ACTB, ACTN1, ADGRF5, AFAP1, AFF3, AGBL4, AGK, AGTRAP, AHCYL1, AHRR, AKAP13, AKAP9, AKT3, ALK, AMACR, AP3S1, APIP, ARHGAP12, ARID1A, ARID1B, ASPSCR1, ATF1, ATG16L1, ATIC, ATP11B, ATP2B4, ATXN1, AUTS2, BAG4, BAIAP2L1, BCAN, BCAP29, BCL10, BCL2, BCLAF1, BCOR, BCORL1, BCR, BICC1, BIRC3, BMX, BRAF, BRD1, BRD3, BRD4, BRD8, BTBD1, C11orf95, C19MC, C3orf62, C5orf30, CAB39L, CAD, CALML4, CAMTA1, CANT1, CAPZA2, CARMN, CARS, CASP7, CCAR2, CCDC6, CCDC67, CCDC88C, CCNB3, CCND1, CCNH, CD101, CD44, CD63, CD74, CD99L2, CDC27, CDH11, CDH17, CDK5RAP2, CDX1, CEACAM5, CEP128, CEP192, CEP89, CHCHD7, CHD7, CIC, CIITA, CITED1, CITED2, CLCN6, CLDN1, CLIP1, CLIP2, CLN6, CLTC, CNNM3, COL12A1, COL17A1, COL1A, COL1A1, COL1A2, COL3A1, COL6A3, COMMD10, CPG, CPSF6, CREB1, CREB3L1, CREB3L2, CREB3L3, CREBBP, CREBZF, CREM, CRTC1, CRTC3, CSF1, CTB.35F21.1, CTNNA3, CTNNB1, CXCR4, CXorf67, DACH1, DAXX, DCTN1, DDIT3, DDX3X, DDX5, DIP2C, DKKL1, DNAH5, DNAJB6, DST, DTD1, DUS4L, DUX4, DUX4L2, E2F1, EEF1AKMT3, EGF, EGFR, EHBP1, EIF3E, ELF5, ELK4, ELN, EMILIN2, EML4, EMP1, EP300, EP400, EPC1, EPC2, EPS15, ERBB2, ERC1, ERG, ERLIN2, ESR1, ESRP1, EST14, ETV1, ETV2, ETV4, ETV5, ETV6, EWSR1, EZR, FAM131B, FAM227A, FER, FEV, FGF1, FGF2, FGFR1, FGFR2, FGFR3, FHIT, FIP1L1, FLI1, FLJ60017, FN1, FOSB, FOXO1, FOXO4, FOXO6, FOXP1, FOXR1, FUS, GCC2, GCNT3, GIT2, GLI1, GNAI1, GOLGA5, GOLGB1, GOPC, GPN1, GPS2, GREB1, GRIK2, GRM1, GSN, GTF2I, GTF3C2, GUCA2B, HAS2, HBA, HBA2, HBB, HENMT1, HERV-K, HERVK17, HEY1, HIP1, HIPK1, HLA-A, HMGA1, HMGA2, HMGN2P46, HNRNPA2B1, HOOK1, HOOK3, HOXD13, HS6ST2, HSPA8, HTN3, HTT, IG, IGF2, IGFBP5, IGH, IGK, IGL, IKBKG, INO80D, IRF2BP2, IRF4/DUSP22, ITD, JAK2, JAZF1, KANSL1, KAT6B, KCTD7, KDM2A, KDM2B, KDM4B, KHDRB52, KHSRP, KIAA1217, KIAA1549, KIAA1598, KIF5B, KIFC3, KIRREL, KLC1, KLF15, KLF17, KLHL29, KLHL7, KLK2, KMT2A, KRAS, KTN1, LACTB2, LAMTOR1, LIFR, LMAN2L, LMNA, LPP, LRIG3, LRRC31, LRRC34, LRRC59, LRRFIP1, LRRFIP2, LSM14A, LUC7L3, LYN, MAD1L1, MAGI3, MALAT1, MALT1, MAML2, MAML3, MAN2A1, MAP3K8, MBD1, MBTD1, MDK, MEAF6, MECOM, MED12, MEF2C, MEIS1, MELK, MET, MGA, MIPOL1, MIR143HG, MITF, MKL2, MKRN1, MLL, MLL4, MLPH, MPRIP, MSANTD3, MSN, MTOR, MXD1, MYB, MYBL1, MYC, MYH10, MYH9, MYO5A, NAB2, NACC2, NAV2, NCOA1, NCOA2, NCOA3, NCOA4, NCOR2, ND4, NDRG1, NF1, NFASC, NFATC1, NFATC2, NFIA, NFIB, NOL4L, NONO, NOS2, NOTCH1, NOTCH2, NOTCH3, NPC1, NPM1, NR4A3, NRG1, NSD3, NTRK1, NTRK2, NTRK3, NUDCD3, NUMA1, NUP160, NUP214, NUP98, NUTM1, NUTM2A, NUTM2B, NUTM2E, OFD1, OGDH, OMD, PAFAH1B2, PAN3, PAPSS1, PARP14, PATZ1, PAX3, PAX5, PAX7, PAX8, PBX1, PBX3, PDCD1LG2, PDE3B, PDE4DIP, PDE8A, PDGFB, PDGFD, PDGFRA, PDGFRB, PDHX, PDPN, PHF1, PIK3C2A, PITPNC1, PLA2G6, PLAG1, PLIN3, PML, POM121, POU1F1, POU3F1, POU5F1, PPAPDC1A, PPARG, PPFIBP1, PPL, PPP1R1B, PPP6R3, PRB3, PRCC, PRDM10, PRG4, PRKAR1A, PRKCA, PRKCB, PRKCD, PRKD1, PRKDC, PRKG1, PSD2, PSMA8, PTCH1, PTEN, PTMA, PTPRD, PTPRJ, PTPRK, PTPRZ1, PVT1, PWWP2A, QKI, RAB2A, RABGAP1L, RAD51, RAD51B, RAD52, RAF1, RANBP2, RARG, RBM10, RCC1, RELA, RET, RFWD2, RNF13, RNF130, RNF213, ROS1, RP11.57H14.3, RPLP1, RPS11, RRBP1, RREB1, RSPO2, RSPO3, RUNX1, S100A10, SCARB1, SCYL3, SDC4, SEC31A, SEC61G, SERINC1, SERPINE1, SET, SETBP1, SFMBT1, SFPQ, SHH, SLC11A2, SLC12A7, SLC16A7, SLC1A2, SLC26A11, SLC34A2, SLC3A2, SLC43A3, SLC45A2, SLC45A3, SLC5A11, SLC7A14, SMAD2, SMAD3, SMARCA4, SMARCA5, SNAPC3, SND1, SNX19, SOS1, SOX6, SP3, SPATA16, SPECC1L, SPTBN1, SQSTM1, SRF, SS18, SS18L1, SSX1, SSX2, SSX2B, SSX4, STARD3, STAT6, STK32B, STRN, SUZ12, SVIL, TACC1, TACC3, TAF15, TAX1BP1, TBL1XR1, TCEA1, TCF12, TCF4, TCF7L2, TEAD1, TENM4, TERT, TFCP2, TFE3, TFEB, TFG, TGFBR3, THBS1, THRAP3, TIMP3, TLN2, TMEM135, TMPRSS2, TNC, TNS3, TOM1L2, TOP2B, TP53, TP53BP1, TPM1, TPM3, TPM4, TPR, TPRG1, TPTEP1, TRA2B, TRIM11, TRIM24, TRIM27, TRIM33, TRIM4, TRIO, TRIT1, TRMT11, TSFM, TTC17, TTC28, TTYH1, UBE2L3, UBR5, ULK4, USP6, VCL, VGLL2, VGLL3, VGLL4, VIM, VMP1, VTI1A, WDR91, WHSC1L1, WIF1, WT1, WWTR1, YAP1, YWHAE, YY1, ZC3H7B, ZCCHC8, ZFP36, ZFPM2, ZKSCAN1, ZKSCAN5, ZMYM2, ZNF207, ZNF217, ZNF278, ZNF423, ZNF444, ZNF521, ZNF595, ZNF737, ZNF9

Unlisted gene 2
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Fusion transcript unlisted gene 2

Frozen tissue
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

Paraffin available
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

Virtual slide
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

Paraffin (8 items)

Number of paraffin blocks with tumour
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Number of paraffin blocks with tumour available in your Centre

TMA
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: if sample of paraffin block is included in a TMA (Tissue Micro Array)
Possible values : No, Yes

Storage centre
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Centre where TMA is stored
Possible values : ANGERS, ARTTIC, BERGONIE, BRUXELLES, CAEN, CCRC, CLERMONT-FERRAND, Cochin, CURIE, DIJON, ERASM, HENRI MONDOR, ICR, IGR, INT, IPSO, KLEUVEN, LAUSANNE, LBPA, LCC, LILLE, MARSEILLE CHU, MARSEILLE IPC, MAUNIHEI, MONTPELLIER, NANCY, NANTES, NICE, P-MAR, Paris Ouest, Rennes, SAINT-CLOUD, SANAV, SLS, STRASBOURG, TOULOUSE, UCBL, UNIPD, Warsaw Cancer Center, Bonn University

Array-CGH
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: array-CGH done
Possible values : Not done, Done non interpretable, Done interpretable

Genomic index
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Value of genomic index
Possible values : GI1, GI2

ExomeSeq
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Not done, Done non interpretable, Done interpretable

MethylSeq
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Not done, Done non interpretable, Done interpretable

Web review
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : if the case has been reviewed using virtual slide
Possible values : No, Yes

Frozen tissue (16 items)

Storage temperature
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Storage temperature of the frozen material according to the scroll menu
Possible values : -80°C, -140°C, Liquid nitrogen

Availability of tissue sample
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Available: frozen material has not been used and is available in the local Center In use: frozen material is currently in use in one or several studies Terminated: there is no frozen material left but nucleic acids (DNA and/or RNA, 0) may be still available
Possible values : Terminated, In use, Available

Number of tubes
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Number of tubes containing tumour fragments stored

Specific translocation
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: karyotype showes a translocation
Possible values : t(X;17)(p11;q25) (Alveolar soft part sarcoma), t(9;22)(q22;q12) (Extraskeletal myxoid chondrosarcoma), t(9;17)(q22;q11) (Extraskeletal myxoid chondrosarcoma), t(9;15)(q22;q21) (Extraskeletal myxoid chondrosarcoma), t(12;22)(q13;q12) (Clear cell sarcoma), t(11;22)(p13;q12) (Desmoplastic small round cell tumor), t(17;22)(q21;q13) (Dermatofibrosarcoma protuberans), t(11;22)(q24;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(21;22)(q22;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(7;22)(p22;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(17;22)(q12;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(2;22)(q33;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(1;16)(q21;q13) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(12;16)(q13;p11) (Liposarcoma, myxoid/round cell), t(12;22)(q13;q12) (Liposarcoma, myxoid/round cell), t(2;13)(q35;q14) (Alveolar rhabdomyosarcoma), t(1;13)(p36;q14) (Alveolar rhabdomyosarcoma), t(X;18)(p11;q11) (Synovial sarcoma)

Array-CGH
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: array-CGH done
Possible values : Not done, Done non interpretable, Done interpretable

Genomic index
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Value of genomic index
Possible values : GI1, GI2

RNA expression profile
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: expression profile done
Possible values : Not done, Done non interpretable, Done interpretable

CINSARC
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Value of CINSARC
Possible values : C1, C2

SNP analysis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: SNP analysis done
Possible values : Not done, Done non interpretable, Done interpretable

miRNA analysis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: miRNA analysis done
Possible values : Not done, Done non interpretable, Done interpretable

ExomeSeq
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Not done, Done non interpretable, Done interpretable

MethylSeq
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Not done, Done non interpretable, Done interpretable

Whole Genome Sequencing
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Not done, Done non interpretable, Done interpretable

Karyotyping
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: karyotype done
Possible values : Not done, Done

Vamp ID
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

Weight of frozen tissue
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Total weigh of frozen tumours fragments in mg

Cell line (11 items)

Cell line reference
Type : Free value	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : Yes
Description : The cell line reference in the center

Number of passages
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Number of passages after put in culture of cells
Possible values : -30, +30

Dilution
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Dilution done at each passage
Possible values : 1/2, 1/4, 1/8, 1/10

Passage frequency
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Number of days between 2 passages

Molecular validation
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Method to check cells are tumorous by chromosome spreading, FISH or sequencing
Possible values : Yes, No, Not available

Array-CGH
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: array-CGH done
Possible values : Not done, Done non interpretable, Done interpretable

Genomic index
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Value of genomic index
Possible values : GI1, GI2

RNA expression profile
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: expression profile done
Possible values : Not done, Done non interpretable, Done interpretable

CINSARC
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Value of CINSARC
Possible values : C1, C2

miRNA analysis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: miRNA analysis done
Possible values : Not done, Done non interpretable, Done interpretable

MultiFISH
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: multiFISH done
Possible values : not done, done interpretable, not interpretable

Blood sample (7 items)

Sample reference
Type : Free value	Content : TEXT	Mandatory : Yes	Multiple values : No	Unique : Yes
Description : The sample reference in the center

Date of sampling
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date on which the sample was removed

Treatment before sampling
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description : No : no treatment of the tumour event before sampling Chemotherapy: the tumour event has been received a chemotherapy before sampling Radiotherapy: radiotherapy on the tumour event before sampling ILP: an isolated limb perfusion procedure has been performed on the tumour event before sampling Other: other treatment has been performed on the tumour event before sampling
Possible values : No, Systemic treatment, Radiotherapy, ILP, Other

Type of material
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Type of material stored
Possible values : Serum, Plasma, Lymphocytes, Total blood

Consent
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: consent obtained from the patient
Possible values : Yes, No, NA

Storage centre
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Centre where TMA is stored
Possible values : ANGERS, ARTTIC, BERGONIE, BRUXELLES, CAEN, CCRC, CLERMONT-FERRAND, Cochin, CURIE, DIJON, ERASM, HENRI MONDOR, ICR, IGR, INT, IPSO, KLEUVEN, LAUSANNE, LBPA, LCC, LILLE, MARSEILLE CHU, MARSEILLE IPC, MAUNIHEI, MONTPELLIER, NANCY, NANTES, NICE, P-MAR, Paris Ouest, Rennes, SAINT-CLOUD, SANAV, SLS, STRASBOURG, TOULOUSE, UCBL, UNIPD, Warsaw Cancer Center, Bonn University

Whole Genome Sequencing
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Not done, Done non interpretable, Done interpretable

Chemotherapy line (11 items)

Rank of Chemotherapy line
Type : Free value	Content : INTEGER	Mandatory : No	Multiple values : No	Unique : No
Description : Rank of Chemotherapy line

Date of first cycle
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date start of cycle of chemotherapy

DateEndCycle
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description :

Performance status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : 0 Fully active, able to carry out all pre-disease performance without restriction1 (Restricted) impairment in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work2 Ambulatory and capable of all selfcare but unable to carry out any work activities for more than 50% of waking hours3 Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours4 Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair
Possible values : 0, 1, 2, 3, 4, NA

Drugs
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : 90Y-Ibritumomab tiuxetan, Abraxane, Abemaciclib, ADEPT, AINS, Aldesleukin, Aldoxorubicin, Alectinib, Alemtuzumab, AMG 706, Amsacrine, Atezolizumab, Avapritinib, Avelumab, Azacitidine, Bendamustine, Bevacizumab, Bezuclastinib/CGT9486, BI2536, Binimetinib, Bintrafusp Alfa , BKM120 - Buparlisib, Bleomycin, Bortezomib, Brostallicin, Busulfan, Cabazitaxel, Capecitabine, Carboplatin, Cabozantinib, Carmustine, Ceritinib, Cetuximab, Chlorambucil, Cisplatin, Cixutumumab, Cladribine, Clofarabine, Cobimetinib, Conatumumab, Crenigacestat, Crenolanib, Crisantaspase, Crizotinib, Cyclophosphamide, Cytarabine, Dabrafenib, Dacarbazine, Dactinomycin, Dalotuzumab, Dasatinib, Daunorubicin, DCC-2618, Deforolimus, Denosumab, Docetaxel, Dovitinib, Doxorubicin, Durvalumab, Emactuzumab, Encorafenib, Entrectinib, Epirubicin, Eribulin, Erlotinib, Etoposide, Everolimus, Evofosfamide, Farmorubicine, FDH, Figitumumab, Fludarabine, Fluorouracil, Fotemustin, FPA0008, Fulvestrant, Gefitinib, Gemcitabine, Gemtuzumab, Gimatecan, Gliadel implants, Halichondrin B, Hormonotherapy, Hydroxycarbamide, Idarubicin, IDRX-42, Ifosfamide, Imatinib, Interferon alpha, Interleukin-2, Iodine-131 tositumomab, Ipilimumab, Irinotecan, JX-594(Pexa-vec), Lapatinib, Larotrectinib, Lenalidomide, Lenvatinib, Leucovorin, Liposomal daunorubicin, Liposomal doxorubicin, Lomustine, Lornatinib, Masitinib, Melphalan, Mercaptopurine, Mesna, Methotrexate, Mitomycin, Mitotane, Mitoxantrone, Motesanib, NB003, NBTXR3, NGR-hTNF, Nilotinib, Nintedanib, Nivolumab, NVL-655, Olaparib, Olaratumab, Ombrabulin, Ontuxizumab (MORAb-004), Oxaliplatin, Paclitaxel, Palbociclib, Palifosfamide, Panitumumab, Panobinostat, Pazopanib, Pembrolizumab, Pemetrexed, Pentostatin, Pexidartinib, Placebo, Ponatinib, Prednisolone, Procarbazine, R1507 (Teprotumumab), Raltitrexed, Ramucirumab, Rasburicase, Regorafenib, Relatlimab, Ribociclib, Ridaforolimus, Ripretinib, Rituximab, RO5045337 / RG7112 (Nutlin), S9788, Satraplatin, Selpercatinib, Siremadlin (HDM201), Sirolimus, Sorafenib, Streptozocin, Sunitinib, Tamoxifen, Tasonermine, Tazemetostat, Tegafur-uracil, Temozolomide, Temsirolimus, Tenoposide, Thalidomide, Thiotepa, Tioguanine, Topotecan, Trabectedin, Trametinib, Trastuzumab, Tremelimumab, Treosulfan, Vinblastine, Vemurafenib, Vincristine, Vindesine, Vinorelbine, Vismodegib, Vistusertib, Warfarin, Other

Clinical trial
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour
Possible values : No, Yes

Clinical trial name
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Clinical trial name according to the scroll menu
Possible values : Clinical trial name to complete, 105SAR301 TAPPAS, 20140114, AB04030, AB07001, AB1010, AB11002, AcSé Crizotinib, ACSE Pembrolizumab, Acsé-eSMART-CSET, ADP-0044-002 - SPEARHEAD 1, ALDOXORUBICIN, ALTGIST, AGADIR, AMG706, AMGEN 20060324, ANGIO-NEXT, ANGIOTAX, ANGIOTAX-PLUS, ANNOUNCE 1, ARO-012 CRENOGIST, ASCEND10, ATEZOGIST, BAY734506, BET115521, BFR14, BKM120, BLU-285-1101, BLU-285-1303 , BO20924, BP27772, BP29428, BROSTALLICINE, CA017-003, CA209-848, CABOGIST, CABONE, CAIRE, CAMN107, CGM097, CHDM201X2103C, CHONDROG, CHONRAD, CISTEM, COMBINAIR 3, CONGRATS, CRAD001C2206, CRAD001X2109, CREATE, CSTI571X2103, CYCLIGIST, DCC2618-03-002 : INTRIGUE, DCC2618-23-001 : INTRIGUE , DESMOPAZ, DOVIGIST, E7389-G000-213, E7438-G000-101, EFC 10145, EISAI E7389, EORTC-1202, EORTC-1403-REECUR, EORTC-1447-STBSG, EORTC-1506-STBSG-ANITA, EORTC-62005, EORTC-62012, EORTC-62022-IRESSA , EORTC-62024, EORTC-62043, EORTC-62052, EORTC-62061-STBSG, EORTC 62113-55115 HGUS, EORTC-62953, EORTC-62972, EORTC-90061-BI2536, EORTC STI571, EREMISS, ESPACE, ESTIM-LBH, ET-743, ETC-002-07, EURO-EWING, EURO-EWING 2012, EUROSARC, EZH-102 (EPIZYME), EZH-202, EZH-501, Far-RMS, FDH-609, FIVE PRIME, GCS O12, GEIS-32, GERICO 14, GIGIST-LB, GIMATECAN, GO29664, GP28153, H6Q-MC-JCAY, I3G-MC-JGCB, I5B-MC-JGDJ : ANNOUNCE, I5B-MC-JGDL : ANNOUNCE 2, I5B-MC-JGDM, I6F-MC-JJCD, IDRX-42-001, IMCLONE, IMADGIST, INTRIGUE DCC 2618 03002, INVICTUS, ISI-JX, IROFULVEN, KCP-330-020 SEAL, KIDES-203, LEE011, LENVAGIST, LMS02, LMS03, LMS04, LOXO-TRAK, MDR-S9788, MEGAMOST, MEKi, MEN 10755, METRO-PD1, METROMAJX, METZOLIMOS, MK 7339, MK 7902-013, MK 8669-DALORI, ML43313-COTESARC, MMT 95, MO29518 basket, MOLMED, MORAb-004, MOST, MOST Plus, MULTISARC C16-40, NAVE-CYCLO, NB003-01, NBTXR3-301, NEOSARCOMICS, NP27872, NP28021, NVL-655-01, OP690, OS 2006, OSII-TTP, PAL-ANGI3, PALETTE, PALSAR, PALSAR II, PAZOGIST, PEAK, PEMBROSARC, PICASSO, PICASSO 3, PIPER, PLX108-10, PO4720, PRESOV, PVNS, RADIOSARP, RAR-IMMUNE, REGISTRI, REGO INTER EWING-1, REGO-SARC, REGOBONE, REGOMAIN, REGOMUNE, REGOSTA, RMS 2005, RT-IMMUNE, RT-SUTENT, SAKK 56/07, SAR-1001, SAR04/0205, SARC011 R1507, SARC021-THRESHOLD, SARCOME 13, SCH717454, SEAL-KCP-330-020 , SHIVA, STARTRK2, STARTRK GO40782, STI 571, STING GSK 208850, SU011248, SUCCEED, SYNFRIZZ, TAIL, TAPISTRY BO41932 , TAPPAS, TARMIC, TAXOGEM, T-DIS, TH-CR-406, TH302, TRAMUNE, TRAST, TRUST, TSAR, VEBASKET, VEG105430 , VINFLUNINE IN104, VIT-0910, XGEVA AMGEN

IndicSTTTLine
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Neo-adjuvant, Adjuvant, Palliative, Maintenance

Progression chemo
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Yes: the patient had progressive disease at the date of last-follow up; no: no progressive disease observed at the date of last follow-up
Possible values : Yes, No, Not available

Date progression chemo
Type : Free value	Content : DATE	Mandatory : No	Multiple values : No	Unique : No
Description : Date of tumour progression under chemotharapy

Best RECIST Response chemo
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : Best response observed during chemotherapy: complete response; partial response; stable disease or progressive disease
Possible values : Complete response, Partial response, Stable disease, Progressive disease, Not evaluable

Immunohistochemistry (7 items)

Positive markers
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fos B , Fox2B, FoxL2, Fli1, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K36M (H3F3B), H3K27, HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Ki67, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NKX2.2, NKX3.1, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, SS18-SSX, STAT 6, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1

Positive focal markers
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K36M (H3F3B), H3K27, HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Pancytokeratin AE1/AE3, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, SS18-SSX, STAT 6, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1

Positive diffuse markers
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, EBV (LMP), E-Cadherin, EGFr, EMA, HHF35, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K27, H3K36M (H3F3B), HBK27, Helicobacter pylori, HER2, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, SS18-SSX, STAT 6, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1

Negative markers
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K27, H3K36M (H3F3B), HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Ki67, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NRAS (Q61R), NSE, NR3C4, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, STAT 6, SS18-SSX, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1

Not interpretable markers
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K27, H3K36M (H3F3B), HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Ki67, KL1, MDM4, MDM2, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, STAT 6, SS18-SSX, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1

Mib1%
Type : Free value	Content : PERCENTAGE	Mandatory : No	Multiple values : No	Unique : No
Description :

Other markers
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

Molecular cytogenetics (76 items)

Translocation analysis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Yes, No

GNAS status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechGNAS
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

RT-PCR
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : No, Yes

Positive transcript (RT-PCR)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : Transcript (PNET), EWSR1-FLI1 (PNET), EWSR1-ERG (PNET), EWSR1-ETV1 (PNET), EWSR1-FEV (PNET), EWSR1-ETV4 (PNET), FUS-ERG (PNET), CIC-DUX4 (Ewing -like), BCOR-CCNB3 (Ewing-like), Transcript (synovial sarcoma), SSI8-SSX1 (synovial sarcoma), SSI8-SSX2 (synovial sarcoma), SSI8-SSX4 (synovial sarcoma), SSI8L1-SSX1 (synovial sarcoma), Transcript (alveolar rhabdomyosarcoma), PAX3-FOXOA1 (alveolar rhabdomyosarcoma), PAX7-FOXOA1 (alveolar rhabdomyosarcoma), PAX3-MLLT7 (alveolar rhabdomyosarcoma), PAX3-NCOA1 (alveolar rhabdomyosarcoma), EWSR1-WT1 (desmoplastic round cell tumour), Transcript (myxoid liposarcoma), FUS-DDIT3 (myxoid liposarcoma), EWSR1-DDIT3 (myxoid liposarcoma), EWSR1-ATF1 (clear cell sarcoma), Transcript (extraskeletal myxoid chondrosarcoma), EWSR1-NR4A3 (extraskeletal myxoid chondrosarcoma), TAF1168-NR4A3 (extraskeletal myxoid chondrosarcoma), TCF12-NR4A3 (extraskeletal myxoid chondrosarcoma), TFG-NR4A3 (extraskeletal myxoid chondrosarcoma), COL1A1-PDGFB (dermatofibrosarcoma protuberans), Transcript (low grade fibromyxoid sarcoma), FUS-CREB3L2 (low grade fibromyxoid sarcoma), FUS-CREB3L1 (low grade fibromyxoid sarcoma), ASPL-TFE3 (alveolar soft part sarcoma), ASPSCR1-TFE3 (alveolar soft part sarcoma), ETV6-NTRK3 (congenital fibrosarcoma), Transcript (endometrial stromal sarcoma), JAZF1/SUZ12 (endometrial stromal sarcoma), YWHAE-FAM22 (endometrial stromal sarcoma), YWHAE-NUTM22A/B (endometrial stromal sarcoma), PAX-MAML3 (sinonasal sarcoma) , PAX3-NCOA1 (sinonasal sarcoma), MYH9-USP6 (fasciitis), EWSR1-PATZ1, EWSR1-ETAF1, CLTC-ALK, hSNF5/INI1 (malignant rhabdoid tumors), EWSR1-CREB3L2, NAB2-STAT6, SRF-NCOA1, FUS/FEV, EWS/NFATc2, EWSR1-CREB1, WWTR1-CAMTA1

Negative transcript (RT-PCR)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : Transcript (PNET), EWSR1-FLI1 (PNET), EWSR1-ERG (PNET), EWSR1-ETV1 (PNET), EWSR1-FEV (PNET), EWSR1-ETV4 (PNET), FUS-ERG (PNET), CIC-DUX4 (Ewing -like), BCOR-CCNB3 (Ewing-like), Transcript (synovial sarcoma), SSI8-SSX1 (synovial sarcoma), SSI8-SSX2 (synovial sarcoma), SSI8-SSX4 (synovial sarcoma), SSI8L1-SSX1 (synovial sarcoma), Transcript (alveolar rhabdomyosarcoma), PAX3-FOXOA1 (alveolar rhabdomyosarcoma), PAX7-FOXOA1 (alveolar rhabdomyosarcoma), PAX3-MLLT7 (alveolar rhabdomyosarcoma), PAX3-NCOA1 (alveolar rhabdomyosarcoma), EWSR1-WT1 (desmoplastic round cell tumour), Transcript (myxoid liposarcoma), FUS-DDIT3 (myxoid liposarcoma), EWSR1-DDIT3 (myxoid liposarcoma), EWSR1-ATF1 (clear cell sarcoma), Transcript (extraskeletal myxoid chondrosarcoma), EWSR1-NR4A3 (extraskeletal myxoid chondrosarcoma), TAF1168-NR4A3 (extraskeletal myxoid chondrosarcoma), TCF12-NR4A3 (extraskeletal myxoid chondrosarcoma), TFG-NR4A3 (extraskeletal myxoid chondrosarcoma), COL1A1-PDGFB (dermatofibrosarcoma protuberans), Transcript (low grade fibromyxoid sarcoma), FUS-CREB3L2 (low grade fibromyxoid sarcoma), FUS-CREB3L1 (low grade fibromyxoid sarcoma), ASPL-TFE3 (alveolar soft part sarcoma), ASPSCR1-TFE3 (alveolar soft part sarcoma), ETV6-NTRK3 (congenital fibrosarcoma), Transcript (endometrial stromal sarcoma), JAZF1/SUZ12 (endometrial stromal sarcoma), YWHAE-FAM22 (endometrial stromal sarcoma), YWHAE-NUTM22A/B (endometrial stromal sarcoma), PAX-MAML3 (sinonasal sarcoma) , PAX3-NCOA1 (sinonasal sarcoma), MYH9-USP6 (fasciitis), EWSR1-ETAF1, EWSR1-PATZ1, CLTC-ALK, hSNF5/INI1 (malignant rhabdoid tumors), EWSR1-CREB3L2, NAB2-STAT6, SRF-NCOA1, FUS/FEV, EWS/NFATc2, EWSR1-CREB1, WWTR1-CAMTA1

Non interpretable transcript (RT-PCR)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : Transcript (PNET), EWSR1-FLI1 (PNET), EWSR1-ERG (PNET), EWSR1-ETV1 (PNET), EWSR1-FEV (PNET), EWSR1-ETV4 (PNET), FUS-ERG (PNET), CIC-DUX4 (Ewing -like), BCOR-CCNB3 (Ewing-like), Transcript (synovial sarcoma), SSI8-SSX1 (synovial sarcoma), SSI8-SSX2 (synovial sarcoma), SSI8-SSX4 (synovial sarcoma), SSI8L1-SSX1 (synovial sarcoma), Transcript (alveolar rhabdomyosarcoma), PAX3-FOXOA1 (alveolar rhabdomyosarcoma), PAX7-FOXOA1 (alveolar rhabdomyosarcoma), PAX3-MLLT7 (alveolar rhabdomyosarcoma), PAX3-NCOA1 (alveolar rhabdomyosarcoma), EWSR1-WT1 (desmoplastic round cell tumour), Transcript (myxoid liposarcoma), FUS-DDIT3 (myxoid liposarcoma), EWSR1-DDIT3 (myxoid liposarcoma), EWSR1-ATF1 (clear cell sarcoma), Transcript (extraskeletal myxoid chondrosarcoma), EWSR1-NR4A3 (extraskeletal myxoid chondrosarcoma), TAF1168-NR4A3 (extraskeletal myxoid chondrosarcoma), TCF12-NR4A3 (extraskeletal myxoid chondrosarcoma), TFG-NR4A3 (extraskeletal myxoid chondrosarcoma), COL1A1-PDGFB (dermatofibrosarcoma protuberans), Transcript (low grade fibromyxoid sarcoma), FUS-CREB3L2 (low grade fibromyxoid sarcoma), FUS-CREB3L1 (low grade fibromyxoid sarcoma), ASPL-TFE3 (alveolar soft part sarcoma), ASPSCR1-TFE3 (alveolar soft part sarcoma), ETV6-NTRK3 (congenital fibrosarcoma), Transcript (endometrial stromal sarcoma), JAZF1/SUZ12 (endometrial stromal sarcoma), YWHAE-FAM22 (endometrial stromal sarcoma), YWHAE-NUTM22A/B (endometrial stromal sarcoma), PAX-MAML3 (sinonasal sarcoma) , PAX3-NCOA1 (sinonasal sarcoma), MYH9-USP6 (fasciitis), EWSR1-PATZ1, EWSR1-ETAF1, CLTC-ALK, hSNF5/INI1 (malignant rhabdoid tumors), EWSR1-CREB3L2, NAB2-STAT6, SRF-NCOA1, FUS/FEV, EWS/NFATc2, EWSR1-CREB1, WWTR1-CAMTA1

FISH
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description : FISH performed
Possible values : No, Yes

Positive (FISH)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : EWSR1 (BA), SSI8 (BA), FOXOA1 (BA), FUS (BA), DDIT3 (BA), ETV6 (BA), PDGFB (BA), COL1A1- PDGFB (fusion), CIC (BA), USP6 (BA), PHF1 (BA), TFE3 (BA), YWHAE (BA), JAZF1 (BA), CAMTA1-WWTR1 (Fusion), ALK (BA), PAX3 (BA), NCOA2 (BA), NR4A3 (BA), H3.3G34W (H3F3A), H3K36M (H3F3B), IDH1/IDH2, GNAS, BCOR, CCNB3, EWSR1-FLI1, EWSR1-ERG, WWTR1 (BA), CKN2A (P16), CAMTA1 (BA), SRF, WT1, NTRK3, VGLL3, CSF1, COL1A1, MGEA5, PTEN, SMARCB1 (INI1), ROS1, RET, CIC-DUX4, PLAG1, NUTM1, FOSB, ERG, BRAF, VGLL2, MAP3K3, WWTR1-CAMTA1 (Fusion), NAFTC3, PRDM10, GRM1, TFCP2, NTRK1, USP2, YAP1, TRIM11, HMGA2, RB1, FN1, APOD, FGFR1, PRKCD

Negative (FISH)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : EWSR1 (BA), SSI8 (BA), FOXOA1 (BA), FUS (BA), DDIT3 (BA), ETV6 (BA), PDGFB (BA), COL1A1- PDGFB (fusion), CIC (BA), JAZF1 (BA), USP6 (BA), PHF1 (BA), TFE3 (BA), YWHAE (BA), CAMTA1-WWTR1 (Fusion), ALK (BA), PAX3 (BA), NCOA2 (BA), NR4A3 (BA), H3.3G34W (H3F3A), H3K36M (H3F3B), IDH1/IDH2, GNAS, BCOR, CCNB3, EWSR1-ERG, EWSR1-FLI1, WWTR1 (BA), CKN2A (P16), CAMTA1 (BA), SRF, WT1, NTRK3, VGLL3, CSF1, COL1A1, MGEA5, PTEN, SMARCB1 (INI1), ROS1, RET, CIC-DUX4, PLAG1, NUTM1, FOSB, HMGA2, ERG, BRAF, VGLL2, MAP3K3, WWTR1-CAMTA1 (Fusion), NAFTC3, PRDM10, GRM1, TFCP2, NTRK1, USP2, YAP1, TRIM11, RB1, FN1, APOD, FGFR1, PRKCD

Non interpretable (FISH)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : CIC (BA), COL1A1- PDGFB (fusion), DDIT3 (BA), ETV6 (BA), EWSR1 (BA), FOXOA1 (BA), FUS (BA), PDGFB (BA), PHF1 (BA), JAZF1 (BA), SSI8 (BA), TFE3 (BA), USP6 (BA), YWHAE (BA), CAMTA1-WWTR1 (Fusion), ALK (BA), PAX3 (BA), NCOA2 (BA), NR4A3 (BA), H3.3G34W (H3F3A), H3K36M (H3F3B), IDH1/IDH2, GNAS, BCOR, CCNB3, EWSR1-FLI1, EWSR1-ERG, WWTR1 (BA), CAMTA1 (BA), CKN2A (P16), SRF, WT1, NTRK3, VGLL3, CSF1, COL1A1, MGEA5, PTEN, SMARCB1 (INI1), ROS1, RET, CIC-DUX4, PLAG1, NUTM1, FOSB, ERG, BRAF, VGLL2, MAP3K3, WWTR1-CAMTA1 (Fusion), NAFTC3, PRDM10, GRM1, TFCP2, NTRK1, USP2, YAP1, TRIM11, RB1, HMGA2, FN1, APOD, FGFR1, PRKCD

GenesMut
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : APC, BRAF, CTNNB1, GNAS, H3F3A, H3F3B, INI1, KIT, MYOD1, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD, SMARCA4, SMARCB1, TP53, Other

OtherGenesMut
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

APC status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, Non amplifiable DNA

TypeTechAPC
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

BRAF status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : V600E, Other, No mutation, Non amplifiable DNA

TypeTechBRAF
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

Exon 3 status (CTNNB1)
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : 41A mutation, 45F mutation, 45P mutation, Other mutation, No mutation, Non amplifiable DNA

TypeTechCTNNB1
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

H3F3A status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechH3F3A
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

H3F3B status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechH3F3B
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

INI1 status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, Non amplifiable DNA

TypeTechINI1
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

KIT status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : Exon9, Exon11, Exon13, Exon17, Other exon, No mutation, No amplifiable DNA

TypeTechKIT
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

KIT Nucleotidic formula exon 9
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

KIT Proteic formula exon 9
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

KIT Nucleotidic formula exon 11
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

KIT Proteic formula exon 11
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

KIT Nucleotidic formula exon 13
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

KIT Proteic formula exon 13
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

KIT Nucleotidic formula exon 17
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

KIT Proteic formula exon 17
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

MYOD1 status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechMYOD1
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

NF1 status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechNF1
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

PDGFRA status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : Exon12, Exon14, Exon18, Other exon, No mutation, No amplifiable DNA

TypeTechPDGFRA
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

PDGFRA Nucleotidic formula exon 12
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

PDGFRA Proteic formula exon 12
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

PDGFRA Nucleotidic formula exon 14
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

PDGFRA Proteic formula exon 14
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

PDGFRA Nucleotidic formula exon 18
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

PDGFRA Proteic formula exon 18
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

SDHA status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechSDHA
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

SDHB status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechSDHB
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

SDHC status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechSDHC
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

SDHD status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechSDHD
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

SMARCA4 status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechSMARCA4
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

SMARCB1 status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, No amplifiable DNA

TypeTechSMARCB1
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : DHPLC, Sequencing, Both, Other

P53 mutation status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Mutation, No mutation, Non amplifiable DNA

TypeTechTP53
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Sequencing, Functional assay, Both, Other

P53 nucleotidic formula 1
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

P53 proteic formula 1
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

P53 nucleotidic formula 2
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

P53 proteic formula 2
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

Amplification analysis
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Yes, No

GenesAmp
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : Yes	Unique : No
Description :
Possible values : CDK4, CMYC, MDM2, Other

OtherGenesAmp
Type : Free value	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :

Result CDK4
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Negative, Positive, Non interpretable

TypeTechCDK4
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : FISH, Q-PCR, Array-CGH, Other

ResultCMYC
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Negative, Positive, Non interpretable

TypeTechCMYC
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : FISH, Q-PCR, Array-CGH, Other

Result MDM2
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Negative, Positive, Non interpretable

TypeTechMDM2
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : FISH, Q-PCR, Array-CGH, Other

P53 polymorphism
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : Yes, No

P53 functional status
Type : Constrained	Content : TEXT	Mandatory : No	Multiple values : No	Unique : No
Description :
Possible values : WT, Mut

SarcomaBCB

Backoffice